Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections. We also found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581 · cited 2×
“Similar experiments were next performed with primary OPC cultures purified from newborn transgenic rat pups expressing GFP under the control the ubiquitous -actin promoter (Okabe et al., 1997).”
MethodMultiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“Multiple sclerosis (MS) is an inflammatory disease of the CNS, leading to chronic demyelination and axonal loss (Compston and Coles, 2008; Trapp and Nave, 2008).”
BackgroundRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 1×
“…creates a permissive environment for remyelination (Williams et al., 2007; Nash et al., 2011), it also contributes to the formation of the glial scar expressing several inhibitory molecules preventing OPC migration and differentiation (Back et al., 2005; Franklin and Ffrench-Constant, 2008;)”
BackgroundPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 1×
“However, in most cases, remyelination fails, resulting in irreversible neurological disability (Chang et al., 2002).”
BackgroundDawson, M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00210-0 · Cited by 927 · cited 1×
“For NG2 staining, positive cells with DAPI nuclei were quantified and separated from each other using high-resolution fluorescence microscopy as reported previously (Reynolds et al., 2002; Dawson et al., 2003).”
MethodHyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation
Back, S. A., Tuohy, T. M. F., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1279 · Cited by 612 · cited 1×
“…creates a permissive environment for remyelination (Williams et al., 2007; Nash et al., 2011), it also contributes to the formation of the glial scar expressing several inhibitory molecules preventing OPC migration and differentiation (Back et al., 2005; Franklin and Ffrench-Constant, 2008;)”
BackgroundHDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-H., Bu, H., Hu, T., Taketo, M. M., van Es, J. H., Clevers, H., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2333 · Cited by 559 · cited 1×
“These factors include retinoid X receptor gamma (Huang et al., 2011), Wnt/ catenin (Fancy et al., 2009; Ye et al., 2009), Notch1/Jagged (John et al., 2002; Nakahara et al., 2009; Zhang et al., 2009), and the myelin inhibitor LINGO-1 (Mi et al., 2009).”
BackgroundRetinoid X receptor gamma signaling accelerates CNS remyelination
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., Kagechika, H., Bauer, J., Zhao, C., Evercooren, A. B.-V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2702 · Cited by 547
Self-citationKotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385 · cited 1×
“Since inflammation is beneficial for remyelination (Kotter et al., 2001; Setzu et al., 2006; Hohlfeld et al., 2007), TFA-12 treatment before disease onset may prevent inflammation and, subsequently, OPC recruitment and remyelination.”
BackgroundThoenen, H., & Sendtner, M. (2002) · Nature Neuroscience · doi:10.1038/nn938 · Cited by 336 · cited 1×
“However, despite some promising results in experimental models, attempts to develop clinical trials based on growth factors have been mainly unsuccessful (Thoenen and Sendtner, 2002).”
Result
Cited by
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Fugger, L., Jensen, L. T., & Rossjohn, J. (2020) · Cell · doi:10.1016/j.cell.2020.03.007 · Cited by 398
Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol
Peh, H. Y., Tan, W. S. D., Liao, W., & Wong, W. S. F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.003 · Cited by 351
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum
Meffre, D., Shackleford, G., Hichor, M., Gorgievski, V., Tzavara, E. T., Trousson, A., Ghoumari, A. M., Deboux, C., Nait Oumesmar, B., Liere, P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424951112 · Cited by 114
“We determined three classes of cell shape on the basis of their ramified morphologies (9), as defined by simple or mild process outgrowth (harboring zero to two and three to four processes emerging from the cell body, respectively) or complex process outgrowth (with more than four processes emerging from the cell body…”
MethodSelf-citationAberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?
Reiche, L., Küry, P., & Göttle, P. (2019) · Cells · doi:10.3390/cells8121591 · Cited by 28
Metadata
- Authors
- Blanchard, B., Heurtaux, T., Garcia, C., Moll, N. M., Caillava, C., Grandbarbe, L., Klosptein, A., Kerninon, C., Frah, M., Coowar, D., Baron-Van Evercooren, A., Morga, E., Heuschling, P., & Nait Oumesmar, B.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2013-07-10
- Volume
- 33
- Issue
- 28
- Pages
- 11633-11642
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2022406306
- Cited by
- 51
- References
- 14
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis. https://app.cochat.ai/papers/10.1523/jneurosci.0774-13.2013
- The paper
- Blanchard, B., Heurtaux, T., Garcia, C., Moll, N. M., Caillava, C., Grandbarbe, L., Klosptein, A., Kerninon, C., Frah, M., Coowar, D., Baron-Van Evercooren, A., Morga, E., Heuschling, P., & Nait Oumesmar, B. (2013). Tocopherol Derivative TFA-12 Promotes Myelin Repair in Experimental Models of Multiple Sclerosis. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0774-13.2013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.